| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8789671 | Surgical Oncology | 2018 | 5 Pages |
Abstract
Palliative PTR may improve the survival outcomes for unresectable mCRC patients. PTR may be preferred, particularly in Kras-mutant patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Levent Korkmaz, Hasan Åenol CoÅkun, Faysal Dane, Bülent Karabulut, Mustafa KaraaÄaç, Devrim Ãabuk, Senem Karabulut, Nuri Faruk Aykan, Hatice Doruk, Nilüfer Avcı, Nazım Serdar Turhal, Mehmet Artaç,